{"id":"https://openalex.org/W4411049873","doi":"https://doi.org/10.1016/s2468-1253(25)00067-6","title":"Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial","display_name":"Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial","publication_year":2025,"publication_date":"2025-06-05","ids":{"openalex":"https://openalex.org/W4411049873","doi":"https://doi.org/10.1016/s2468-1253(25)00067-6","pmid":"https://pubmed.ncbi.nlm.nih.gov/40484014"},"language":"en","primary_location":{"id":"doi:10.1016/s2468-1253(25)00067-6","doi":"https://doi.org/10.1016/s2468-1253(25)00067-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2468-1253(25)00067-6","pdf_url":null,"source":{"id":"https://openalex.org/S2530914053","display_name":"The Lancet. Gastroenterology & hepatology","issn_l":"2468-1156","issn":["2468-1156","2468-1253"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Gastroenterology & Hepatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052059601","display_name":"Rohit Seth Loomba","orcid":"https://orcid.org/0000-0002-4845-9991","observed_orcids":["https://orcid.org/0000-0002-4845-9991"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rohit Loomba","raw_affiliation_strings":["MASLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California at San Diego, La Jolla, California, USA. Electronic address: roloomba@health.ucsd.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MASLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California at San Diego, La Jolla, California, USA. Electronic address: roloomba@health.ucsd.edu","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091028785","display_name":"Kris V. Kowdley","orcid":"https://orcid.org/0000-0002-8553-3652","observed_orcids":["https://orcid.org/0000-0002-8553-3652"]},"institutions":[{"id":"https://openalex.org/I170632171","display_name":"Washington State University Spokane","ror":"https://ror.org/04vfs5h36","country_code":"US","type":"education","lineage":["https://openalex.org/I170632171","https://openalex.org/I72951846"]},{"id":"https://openalex.org/I4210119989","display_name":"Liver Institute Northwest","ror":"https://ror.org/02jrddb23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210119989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kris V Kowdley","raw_affiliation_strings":["Liver Institute Northwest, Velocity Clinical Research, Seattle, WA, USA; Elson S Floyd College of Medicine, Washington State University, Spokane, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Institute Northwest, Velocity Clinical Research, Seattle, WA, USA; Elson S Floyd College of Medicine, Washington State University, Spokane, WA, USA","institution_ids":["https://openalex.org/I170632171","https://openalex.org/I4210119989"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jose Rodriguez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jose Rodriguez","raw_affiliation_strings":["Southwest General Healthcare Center, Fort Myers, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southwest General Healthcare Center, Fort Myers, FL, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nomita J Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nomita J Kim","raw_affiliation_strings":["Accelemed Research, Austin, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Accelemed Research, Austin, TX, USA","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alina Maria Alvarez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alina Maria Alvarez","raw_affiliation_strings":["Century Research, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Century Research, Miami, FL, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084625858","display_name":"Linda Morrow","orcid":"https://orcid.org/0000-0003-3252-4477","observed_orcids":["https://orcid.org/0000-0003-3252-4477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda Morrow","raw_affiliation_strings":["Prosciento, Chula Vista, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prosciento, Chula Vista, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004104346","display_name":"Brenda I. Jeglinski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270318","display_name":"Boston Pharmaceuticals (United States)","ror":"https://ror.org/00fk46e73","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270318"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenda Jeglinski","raw_affiliation_strings":["Boston Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4405270318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040949476","display_name":"Alicia Clawson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270318","display_name":"Boston Pharmaceuticals (United States)","ror":"https://ror.org/00fk46e73","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270318"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alicia Clawson","raw_affiliation_strings":["Boston Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4405270318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101406225","display_name":"Swapan K. Chowdhury","orcid":"https://orcid.org/0000-0003-4004-8925","observed_orcids":["https://orcid.org/0000-0003-4004-8925"]},"institutions":[{"id":"https://openalex.org/I4405270318","display_name":"Boston Pharmaceuticals (United States)","ror":"https://ror.org/00fk46e73","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270318"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Swapan Chowdhury","raw_affiliation_strings":["Boston Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4405270318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105777346","display_name":"Gerard Bain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270318","display_name":"Boston Pharmaceuticals (United States)","ror":"https://ror.org/00fk46e73","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270318"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerard Bain","raw_affiliation_strings":["Boston Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4405270318"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113587863","display_name":"Tatjana M. Odrljin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270318","display_name":"Boston Pharmaceuticals (United States)","ror":"https://ror.org/00fk46e73","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270318"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tatjana Odrljin","raw_affiliation_strings":["Boston Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4405270318"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5052059601"],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":null,"fwci":17.9988,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.99604203,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"10","issue":"8","first_page":"734","last_page":"745"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9419000148773193,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9419000148773193,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.05550000071525574,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgf21-analogues","display_name":"FGF21 analogues","score":0.9789999723434448},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.6850000023841858},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.49799999594688416},{"id":"https://openalex.org/keywords/liver-inflammation","display_name":"liver inflammation","score":0.6230000257492065},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6389999985694885},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8370000123977661},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8519999980926514},{"id":"https://openalex.org/keywords/subcutaneous-injection","display_name":"subcutaneous injection","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8445749282836914},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8132277727127075},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7188824415206909},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5929819941520691},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5773005485534668},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.574525773525238},{"id":"https://openalex.org/C2779478299","wikidata":"https://www.wikidata.org/wiki/Q2335423","display_name":"Steatohepatitis","level":4,"score":0.5291799902915955},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4736700654029846},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4417341649532318},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.34873437881469727},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.34467002749443054},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.30248844623565674},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.17632272839546204},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08066684007644653},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005234","descriptor_name":"Fatty Liver","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s2468-1253(25)00067-6","doi":"https://doi.org/10.1016/s2468-1253(25)00067-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2468-1253(25)00067-6","pdf_url":null,"source":{"id":"https://openalex.org/S2530914053","display_name":"The Lancet. Gastroenterology & hepatology","issn_l":"2468-1156","issn":["2468-1156","2468-1253"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Gastroenterology & Hepatology","raw_type":"journal-article"},{"id":"pmid:40484014","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40484014","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The lancet. Gastroenterology & hepatology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320317439","display_name":"Boston Pharmaceuticals","ror":"https://ror.org/00fk46e73"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1969706853","https://openalex.org/W1975918963","https://openalex.org/W1984913749","https://openalex.org/W2050259739","https://openalex.org/W2062618014","https://openalex.org/W2204688218","https://openalex.org/W2903736473","https://openalex.org/W2905440332","https://openalex.org/W3004950447","https://openalex.org/W3047314584","https://openalex.org/W3082261340","https://openalex.org/W3095442103","https://openalex.org/W3193653742","https://openalex.org/W4214523522","https://openalex.org/W4234890939","https://openalex.org/W4292830211","https://openalex.org/W4309750511","https://openalex.org/W4315619045","https://openalex.org/W4318542444","https://openalex.org/W4381848486","https://openalex.org/W4381884589","https://openalex.org/W4387310990","https://openalex.org/W4387878772","https://openalex.org/W4388603539","https://openalex.org/W4398143784","https://openalex.org/W4399461049"],"related_works":["https://openalex.org/W7128035858","https://openalex.org/W7135052058","https://openalex.org/W7144172094","https://openalex.org/W7204471621","https://openalex.org/W4399459192","https://openalex.org/W4413269980","https://openalex.org/W7162522354","https://openalex.org/W4384946741","https://openalex.org/W7140129464","https://openalex.org/W4414014783"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":38},{"year":2025,"cited_by_count":14}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-10-10T00:00:00"}